BGASX
Price
$18.34
Change
-$0.20 (-1.08%)
Updated
Sep 2 closing price
Net Assets
715.2M
RPEBX
Price
$68.64
Change
-$0.54 (-0.78%)
Updated
Sep 2 closing price
Net Assets
158.26B
Interact to see
Advertisement

BGASX vs RPEBX

Header iconBGASX vs RPEBX Comparison
Open Charts BGASX vs RPEBXBanner chart's image
Baillie Gifford Global Alpha Equities I
Price$18.34
Change-$0.20 (-1.08%)
VolumeN/A
Net Assets715.2M
American Funds New Perspective R2E
Price$68.64
Change-$0.54 (-0.78%)
VolumeN/A
Net Assets158.26B
BGASX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BGASX vs. RPEBX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGASX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 158B vs. BGASX (715M). BGASX pays higher dividends than RPEBX: BGASX (1.05) vs RPEBX (0.12). BGASX was incepted earlier than RPEBX: BGASX (8 years) vs RPEBX (11 years). RPEBX (1.21) is less costly to investors than BGASX (0.75). BGASX is a more actively managed with annual turnover of: 28.00 vs. RPEBX (24.00). BGASX has a lower initial minimum investment than RPEBX: BGASX (0) vs RPEBX (250). RPEBX annual gain was more profitable for investors over the last year : 9.57 vs. BGASX (4.31). RPEBX return over 5 years is better than : 29.27 vs. BGASX (-0.12).
BGASXRPEBXBGASX / RPEBX
Total Expense Ratio0.751.2162%
Annual Report Gross Expense Ratio0.751.2162%
Fund Existence8 years11 years-
Gain YTD13.98413.699102%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets715M158B0%
Annual Yield % from dividends1.050.12872%
Returns for 1 year4.319.5745%
Returns for 3 years35.6344.3780%
Returns for 5 years-0.1229.27-0%
Returns for 10 yearsN/A92.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VATE5.560.15
+2.77%
INNOVATE Corp
OKLO73.59-0.05
-0.07%
Oklo Inc.
ADNT24.45-0.35
-1.41%
Adient plc
CHCT15.17-0.24
-1.56%
Community Healthcare Trust
BDRX5.36-0.18
-3.25%
Biodexa Pharmaceuticals plc